Answers are grounded in this paper and cite their sources.
Study evaluated TNF-alpha and IL-10 in preeclampsia, indicating their roles in clinical outcomes.
Background Preeclampsia (PE) is a multifactorial hypertensive disorder of pregnancy characterized by systemic inflammation and endothelial dysfunction. Aberrant immune responses, particularly an imbalance between pro-inflammatory and anti-inflammatory cytokines, have been implicated in its pathogenesis. This study evaluated the expression of tumor necrosis factor-alpha (TNF-a) and interleukin-10 (IL-10) in early-onset (EOPE) and late-onset preeclampsia (LOPE) compared with normotensive pregnancies, and examined their correlation with clinical, laboratory, and perinatal out-comes. Materials and methods A total of 200 pregnant women were recruited, including EOPE (n=50), LOPE (n=50), and healthy controls (n=100). Demographic, clinical, and laboratory parameters were recorded. Quantitative real-time PCR was used to assess mRNA expression of TNF-a and IL-10 in peripheral blood samples. Statistical analyses included ANOVA with post-hoc testing, Pearson’s correlation, and regression modeling. Results EOPE and LOPE groups demonstrated significantly higher systolic and diastolic blood pressures and proteinuria compared with controls (p<0.001). TNF-α expression was markedly upregulated in EOPE compared with LOPE and controls (p<0.001), whereas IL-10 expression was significantly downregulated in both PE groups (p<0.01). The TNF-α/IL-10 ratio was highest in EOPE, reflecting a pronounced pro-inflammatory shift. Correlation analysis revealed that TNF-a positively correlated with blood pressure, proteinuria, and adverse perinatal outcomes, while IL-10 levels negatively correlated with these parameters. Composite analysis integrating molecular and clinical data reinforced the stronger immune dysregulation in EOPE compared with LOPE. Conclusion This study highlights a distinct immunological profile in preeclampsia characterized by elevated TNF-α, reduced IL-10, and an exaggerated TNF-α/IL-10 ratio, particularly in EOPE. These findings underscore the role of immune imbalance in disease severity and suggest that cytokine profiling may serve as a potential biomarker and therapeutic target in preeclampsia.
No takes yet. Share an insight, caveat, or question.
Ashalatha et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: